[HTML][HTML] Efficacy and safety of tocilizumab and baricitinib among patients hospitalized for COVID-19: a systematic review and meta-analysis
J Zhang, X Fan, X Zhang, F Jiang, Y Wu… - Frontiers in …, 2023 - frontiersin.org
Introduction: Tocilizumab and baricitinib are recommended treatment options for COVID-19
patients with hyperinflammatory response; however, there is a lack of systematic review …
patients with hyperinflammatory response; however, there is a lack of systematic review …
Efficacy and safety of tocilizumab and baricitinib among patients hospitalized for COVID-19: a systematic review and meta-analysis
J Zhang, X Fan, X Zhang, F Jiang… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
Introduction: Tocilizumab and baricitinib are recommended treatment options for COVID-19
patients with hyperinflammatory response; however, there is a lack of systematic review …
patients with hyperinflammatory response; however, there is a lack of systematic review …
[HTML][HTML] Efficacy and safety of tocilizumab and baricitinib among patients hospitalized for COVID-19: a systematic review and meta-analysis
J Zhang, X Fan, X Zhang, F Jiang, Y Wu… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Introduction: Tocilizumab and baricitinib are recommended treatment options for COVID-19
patients with hyperinflammatory response; however, there is a lack of systematic review …
patients with hyperinflammatory response; however, there is a lack of systematic review …
Efficacy and safety of tocilizumab and baricitinib among patients hospitalized for COVID-19: a systematic review and meta-analysis
J Zhang, X Fan, X Zhang, F Jiang, Y Wu… - Frontiers in …, 2023 - europepmc.org
Introduction: Tocilizumab and baricitinib are recommended treatment options for COVID-19
patients with hyperinflammatory response; however, there is a lack of systematic review …
patients with hyperinflammatory response; however, there is a lack of systematic review …
[PDF][PDF] Efficacy and safety of tocilizumab and baricitinib among patients hospitalized for COVID-19: a systematic review and meta-analysis
J Zhang, X Fan, X Zhang, F Jiang, Y Wu, B Yang, X Li… - 2023 - scienceopen.com
Objective: This review was conducted to evaluate the efficacy and safety of tocilizumab and
baricitinib in the treatment of hospitalized patients with COVID-19. Methods: Relevant …
baricitinib in the treatment of hospitalized patients with COVID-19. Methods: Relevant …
Efficacy and safety of tocilizumab and baricitinib among patients hospitalized for COVID-19: a systematic review and meta-analysis.
J Zhang, X Fan, X Zhang, F Jiang, Y Wu… - Frontiers in …, 2023 - europepmc.org
Introduction: Tocilizumab and baricitinib are recommended treatment options for COVID-19
patients with hyperinflammatory response; however, there is a lack of systematic review …
patients with hyperinflammatory response; however, there is a lack of systematic review …